Literature DB >> 29956026

Multiple clinical features of Huntington's disease correlate with mutant HTT gene CAG repeat lengths and neurodegeneration.

Sonia Podvin1, Holly T Reardon1, Katrina Yin1, Charles Mosier1, Vivian Hook2,3,4.   

Abstract

Huntington's disease (HD) is a fatal neurodegenerative disease caused by mutant HTT gene expansions of CAG triplet repeat numbers that are inherited in an autosomal dominant manner. HD patients display multiple clinical features that are correlated with HTT CAG repeat numbers that include age of disease onset, motor dysfunction, cognitive deficits, compromised daily living capacity, and brain neurodegeneration. It is important to understand the significant relationships of the multiple HD clinical deficits correlated with the number of mutant HTT CAG expansions that are the genetic basis for HD disabilities. Therefore, this review highlights the significant correlations of the HD clinical features of age of onset, motor and cognitive disabilities, decline in living capabilities, weight loss, risk of death, and brain neurodegeneration with respect to their associations with CAG repeat lengths of the HTT gene. Quantitative HTT gene expression patterns analyzed in normal adult human brain regions demonstrated its distribution in areas known to undergo neurodegeneration in HD, as well as in other brain regions. Future investigation of the relationships of the spectrum of clinical HD features with mutant HTT molecular mechanisms will be important to gain understanding of how mutant CAG expansions of the HTT gene result in the devastating disabilities of HD patients.

Entities:  

Keywords:  Cognition disorders; Huntington’s disease; Motor disorders; Neurodegeneration; Polyglutamine

Mesh:

Substances:

Year:  2018        PMID: 29956026     DOI: 10.1007/s00415-018-8940-6

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  9 in total

Review 1.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update. II. Hyperkinetic disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-24       Impact factor: 3.575

2.  Sleep in Huntington's disease: a systematic review and meta-analysis of polysomongraphic findings.

Authors:  Ye Zhang; Rong Ren; Linghui Yang; Junying Zhou; Yun Li; Jie Shi; Lin Lu; Larry D Sanford; Xiangdong Tang
Journal:  Sleep       Date:  2019-10-09       Impact factor: 5.849

Review 3.  The impact of proteostasis dysfunction secondary to environmental and genetic causes on neurodegenerative diseases progression and potential therapeutic intervention.

Authors:  Abdelmagid M Elmatboly; Ahmed M Sherif; Dalia A Deeb; Amira Benmelouka; May N Bin-Jumah; Lotfi Aleya; Mohamed M Abdel-Daim
Journal:  Environ Sci Pollut Res Int       Date:  2020-02-19       Impact factor: 4.223

Review 4.  PGC-1α, Sirtuins and PARPs in Huntington's Disease and Other Neurodegenerative Conditions: NAD+ to Rule Them All.

Authors:  Alejandro Lloret; M Flint Beal
Journal:  Neurochem Res       Date:  2019-05-07       Impact factor: 3.996

5.  Mutant Huntingtin Protein Interaction Map Implicates Dysregulation of Multiple Cellular Pathways in Neurodegeneration of Huntington's Disease.

Authors:  Sonia Podvin; Sara Brin Rosenthal; William Poon; Enlin Wei; Kathleen M Fisch; Vivian Hook
Journal:  J Huntingtons Dis       Date:  2022

Review 6.  Role of mitophagy in the neurodegenerative diseases and its pharmacological advances: A review.

Authors:  Qixia Wang; Haoyuan Xue; Yundi Yue; Shiqi Hao; Shu-Hong Huang; Zhaoqiang Zhang
Journal:  Front Mol Neurosci       Date:  2022-10-04       Impact factor: 6.261

7.  Enhanced Clearance of Neurotoxic Misfolded Proteins by the Natural Compound Berberine and Its Derivatives.

Authors:  Paola Rusmini; Riccardo Cristofani; Barbara Tedesco; Veronica Ferrari; Elio Messi; Margherita Piccolella; Elena Casarotto; Marta Chierichetti; Maria Elena Cicardi; Mariarita Galbiati; Cristina Geroni; Paolo Lombardi; Valeria Crippa; Angelo Poletti
Journal:  Int J Mol Sci       Date:  2020-05-13       Impact factor: 5.923

8.  Chromosome Instability and Mosaic Aneuploidy in Neurodegenerative and Neurodevelopmental Disorders.

Authors:  Huntington Potter; Heidi J Chial; Julbert Caneus; Mihret Elos; Nina Elder; Sergiy Borysov; Antoneta Granic
Journal:  Front Genet       Date:  2019-11-07       Impact factor: 4.599

9.  Genetic Risk Underlying Psychiatric and Cognitive Symptoms in Huntington's Disease.

Authors:  Natalie Ellis; Amelia Tee; Branduff McAllister; Thomas Massey; Duncan McLauchlan; Timothy Stone; Kevin Correia; Jacob Loupe; Kyung-Hee Kim; Douglas Barker; Eun Pyo Hong; Michael J Chao; Jeffrey D Long; Diane Lucente; Jean Paul G Vonsattel; Ricardo Mouro Pinto; Kawther Abu Elneel; Eliana Marisa Ramos; Jayalakshmi Srinidhi Mysore; Tammy Gillis; Vanessa C Wheeler; Christopher Medway; Lynsey Hall; Seung Kwak; Cristina Sampaio; Marc Ciosi; Alastair Maxwell; Afroditi Chatzi; Darren G Monckton; Michael Orth; G Bernhard Landwehrmeyer; Jane S Paulsen; Ira Shoulson; Richard H Myers; Erik van Duijn; Hugh Rickards; Marcy E MacDonald; Jong-Min Lee; James F Gusella; Lesley Jones; Peter Holmans
Journal:  Biol Psychiatry       Date:  2019-12-17       Impact factor: 12.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.